drugset / Trial / NCT02542969

Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin

NCT02542969

Phase 1 Completed 25 enrolled Madrigal Pharmaceuticals, Inc. Celerion · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of rosuvastatin and/or simvastatin in healthy male subjects and female subjects not of child-bearing potential.

Timeline

Start
2015-09
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Resmetirom Small molecule
Subject Rosuvastatin Small molecule
Subject Simvastatin Small molecule

Indications

No indication recorded.